mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.01 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.01 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.01 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.01 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.02 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.02 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.02 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.02 |